In the News

Health News Review Interview with Dr. Laura Esserman on Rethinking DCIS

When a recent article on “Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ” was published in JAMA Oncology, Dr. Laura Esserman, a surgeon and breast cancer specialist at the University of California San Francisco, co-authored an editorial, “Rethinking the Standard for Ductal Carcinoma In Situ Treatment.”

Health News Review publisher Gary Schwitzer talked with Dr. Esserman about the paper, DCIS, and new research initiatives. “Dr. Esserman pushes a great deal of rethinking about breast cancer screening and treatment,” says Schwitzer, “DCIS is one of her targets.”

Breast Cancer Consortium

Read More